Skip to main content

Table 2 Summary of associations in entire population

From: Nuclear receptor coregulator SNP discovery and impact on breast cancer risk

SNP

Genotypes

Cases

Controls

OR

95% CI

P

SRC-1

CC (%)

1147 (94.2)

1432 (94.9)

1

  

rs1804645

CT (%)

69 (5.6)

77 (5.1)

1.11

0.80-1.56

0.510

P1272S

TT (%)

2 (0.2)

0 (0.0)

-

-

-

  

[CT + TT]<-> [CC]

1.15

0.82-1.60

0.405

SRC-3

CC (%)

1089 (89.9)

1330 (89.3)

1

  

rs6094752

CT (%)

116 (9.6)

152 (10.2)

0.93

0.72-1.20

0.587

C218R

TT (%)

6 (0.5)

8 (0.5)

0.92

0.32-2.65

0.871

  

[CT + TT]<-> [CC]

0.93

0.73-1.19

0.575

SRC-3

GG (%)

988 (80.8)

1207 (80.3)

1

  

rs2230782

CG (%)

226 (18.5)

272 (18.1)

1.11

0.83-1.23

0.881

Q586H

CC (%)

9 (0.7)

24 (1.6)

0.46

0.21-0.99

0.042

  

[CC]<-> [GG + GC]

0.45*

0.21-0.98*

0.041*

SRC-3

AA (%)

1011 (82.7)

1240 (82.2)

1

  

rs2076546

AG (%)

202 (16.5)

249 (16.5)

0.99

0.25-1.22

0.961

T960T

GG (%)

9 (0.8)

20 (1.3)

0.55

0.25-1.22

0.135

  

[AG + GG]<-> [AA]

0.96°

0.79-1.17°

0.702°

SMRT

GG (%)

789 (66.2)

1004 (67.6)

1

  

rs2229840

AG (%)

357 (30.0)

423 (28.5)

1.07

0.91-1.27

0.407

A1706T

AA (%)

45 (3.8)

57 (3.9)

1.01

0.67-1.50

0.982

  

[AG + GG]<-> [AA]

1.06

0.91-1.25

0.441

  1. Odds ratios (OR) with 95% confidence intervals (95% CI) and P-values. Please note that the results excluding samples (345 cases/1190 controls) that have been analysed in a previous study (14) are *OR = 0.37, 95%CI = 0.13-1.08, p = 0.059 and °OR = 1.13, 95%CI = 0.80-1.59, p = 0.491.